Valosin-containing Protein is Cargo in Amyloid Precursor Protein Extracellular Vesicles
Lue, Y.; Abdullah, M.; Healy, L. R.; Tambini, M. D.
Show abstract
The Amyloid Precursor Protein (APP), a genetic cause of Alzheimers disease (AD), is a type-I transmembrane protein that is metabolized by proteolysis in the endolysomal system. APP and its metabolites are secreted by cells in extracellular vesicles (EVs). To study the function of APP-containing EVs, we isolated App-EVs from rat primary neuronal conditioned media and proteomic analysis identified the Valosin-containing protein (Vcp) as molecular cargo. Pharmacological modulation of Vcp activity was found to alter App processing and global EV secretion in rat primary neurons. AD-associated knock-in App mutations were found to alter the abundance of App-EVs and the trafficking of App metabolites within App-EVs, in a manner related to the epitopes generated by the nonamyloidogenic processing of App. The presence of Vcp suggests a role for App-EVs in the clearance of protein aggregates.
Matching journals
The top 11 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Endo-lysosomal Aβ concentration and pH enable formation of Aβ oligomers that potently induce Tau missorting 96%
- SKA2 regulated hyperactive secretory autophagy drives neuroinflammation-induced neurodegeneration 95%
- Opposing roles of physiological and pathological amyloid-β on synapses in live human brain slice cultures 95%
Similar papers in this journal
- Vesicular Rps6 released by astrocytes regulate local translation and enhance synaptic markers in neurons 96%
- Intranasally Administered EVs from hiPSC-derived NSCs Alter the Transcriptomic Profile of Activated Microglia and Conserve Brain Function in an Alzheimer's Model 94%
- Influence of species and processing parameters on recovery and content of brain tissue-derived extracellular vesicles 93%
Similar papers in this journal
- β-Amyloid Induces Microglial Expression of GPC4 and APOE Leading to Increased Neuronal Tau Pathology and Toxicity 97%
- Multi-modal Proteomic Characterization of Lysosomal Function and Proteostasis in Progranulin-Deficient Neurons 95%
- APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology 94%
Similar papers in this journal
- Cystatin F (Cst7) drives sex-dependent changes in microglia in an amyloid-driven model of Alzheimer's Disease 95%
- Aβ-driven nuclear pore complex dysfunction alters activation of necroptosis proteins in a mouse model of Alzheimer's Disease 95%
- Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.